
Treatment GuideJust DiagnosedSex & DatingAfrican AmericanStigmaAsk the HIV DocPrEP En EspañolNewsVoicesPrint IssueVideo
CONTACTCAREER OPPORTUNITIESADVERTISE WITH USPRIVACY POLICYPRIVACY PREFERENCESTERMS OF USELEGAL NOTICE
© 2023 Pride Publishing Inc.
All Rights reserved
All Rights reserved
Don’t miss our latest news! Sign up today for our free newsletter.
By continuing to use our site, you agree to our Private Policy and Terms of Use.
A four-week course of antiretroviral drugs to prevent HIV infection begun within 72 hours of exposure to the virus does not guarantee remaining HIV-free, according to researchers at the University of California, San Francisco. They followed 702 people given postexposure prophylaxis after nonoccupational exposures to HIV, and at a 12-week follow-up after treatment seven people were shown to have contracted HIV. Three of the seven had no other exposures to HIV and were determined to have seroconverted despite taking the anti-HIV drugs; it was unclear whether the remaining four had been exposed to HIV at other times. 'PEP is not completely effective in preventing HIV infection following nonoccupational exposure. Therefore, primary prevention remains essential,' the researches wrote in the journal Clinical Infectious Diseases.
Want more breaking equality news & trending entertainment stories?
Check out our NEW 24/7 streaming service: the Advocate Channel!
Download the Advocate Channel App for your mobile phone and your favorite streaming device!
From our Sponsors
Most Popular
Don’t miss our latest news! Sign up today for our free newsletter.
Plus: Featured Video
Latest Stories
‘Kokomo City’ Gives a Searing Look Into Lives of Black Trans Sex Workers
August 18 2023 12:40 PM